antisense oligonucleotides: an emerging area in drug development
Published 5 months ago • 2.7K plays • Length 2:31Download video MP4
Download video MP3
Similar videos
-
2:56
boc sciences will participate in tides usa: oligonucleotide & peptide therapeutics 2024
-
56:31
webinar: targeting rna structure as a therapeutic strategy
-
5:30
tides usa oligonucleotide & peptide therapeutics conference boc sciences
-
2:16
peptide oligonucleotide conjugation | how does it work?
-
19:33
oligo meeting 2017 - rnai drug discovery
-
23:35
antisense oligonucleotide therapy
-
9:25
what are oligonucleotide therapeutics, and how do they work?
-
58:05
antisense oligonucleotide therapy for als
-
49:46
how to design antisense oligonucleotides for high on-target potency and minimal off-target effect
-
24:46
asos - antisense oligonucleotides: what they are and how they work
-
13:49
oligonucleotide therapeutics: new drugs that could stop covid-19
-
1:04:31
antisense oligonucleotide based therapies for inherited retinal diseases from mutation to clinical
-
25:00
oligonucleotide therapeutic development: pre-clinical and translational considerations
-
54:11
shalini andersson: developing oligonucleotides into therapies
-
1:16:45
antisense oligonucleotides- mechanisms of action and rational design
-
25:14
regulatory applications of a nonclinical database for oligonucleotide therapeutics at u.s. fda
-
2:03:11
education workshop (2021 annual meeting)
-
3:51
treating disease at the rna level with oligonucleotides
-
2:13
fixing genes with antisense oligonucleotides (asos)
-
23:23
oligonucleotides as a new therapeutic class: progress report & prescription
-
25:30
hot topics | gene expression | modulating with oligonucleotide-based therapies